|Bid||25.92 x 900|
|Ask||28.43 x 800|
|Day's Range||28.21 - 28.44|
|52 Week Range||18.21 - 37.96|
|Beta (5Y Monthly)||1.05|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||36.59|
PLANEGG, MUNICH, GERMANY / ACCESSWIRE / December 2, 2020 / MorphoSys AG (FSE:MOR; Prime Standard Segment; MDAX & TecDAX; NASDAQ:MOR) announced today that its licensee Janssen Research & Development, LLC.
PLANEGG / MUNICH, GERMANY / ACCESSWIRE / December 1, 2020 / MorphoSys (FSE:MOR) Prime Standard Segment; MDAX & TecDAX; (NASDAQ:MOR) announced today that Thomas Biegi joins the company as Vice President, Head of Corporate Communications, effective December 1, 2020.
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge funds and institutional investors spend millions of dollars on analysts with MBAs and PhDs, who are industry experts and well connected to other industry and media insiders on top of that. Individual investors can piggyback […]